Y. Ko

发表

Angiotensin II induces formation of the early growth response gene‐1 protein in rat vascular smooth muscle cells

L. Neyses, H. Vetter, A. Sachinidis, 1992, FEBS letters.

Cholesterol enhances platelet-derived growth factor-BB-induced [Ca2+]i and DNA synthesis in rat aortic smooth muscle cells.

M. Liu, V. Harth, H. Vetter, 1997, Hypertension.

Evidence for cardiovascular remodeling in a patient with Bartter's syndrome

H. Vetter, R. Düsing, M. Ludwig, 1994, The clinical investigator.

Evidence for cardiovascular remodeling in a with Bartter's syndrome

H. Vetter, M. Ludwig, Y. Ko, 1994 .

Plasma lipids and lipoproteins and essential hypertension

M. Flesch, K. Kraft, H. Vetter, 1994, The clinical investigator.

Occurrence of urinary tract tumors in miners highly exposed to dinitrotoluene.

T. Brüning, H. Bolt, R. Thier, 1999, Journal of occupational and environmental medicine.

Stromal cell‐derived factor 1α (SDF‐1α) induces gene‐expression of early growth response‐1 (Egr‐1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation

S. Stier, H. Vetter, A. Sachinidis, 2003, Cell proliferation.

Reliability of non-invasively acquired human genomic DNA as a substrate for real-time PCR-assisted analysis of genetic polymorphisms

H. Bolt, H. Vetter, T. Neuhaus, 2004, Archives of Toxicology.

Carbocyclic thromboxane A2 enhances the angiotensin II-induced DNA synthesis in smooth muscle cells.

H. Vetter, A. Sachinidis, K. El-Haschimi, 1996, European journal of pharmacology.

Effect of the Na+/H+ antiport inhibitor Hoe 694 on the angiotensin II‐induced vascular smooth muscle cell growth

H. Vetter, A. Sachinidis, R. Düsing, 1996, British Journal of Pharmacology.

Thromboxane A2 and vascular smooth muscle cell proliferation.

M. Böhm, M. Flesch, K. Schrör, 1995, Hypertension.

Effects of TCV-116 and CV-11974 on angiotensin II-induced responses in vascular smooth muscle cells.

M. Flesch, H. Vetter, A. Sachinidis, 1995, European journal of pharmacology.

The induction of early response genes in rat smooth muscle cells by PDGF‐AA is not sufficient to stimulate DNA‐synthesis

H. Vetter, A. Sachinidis, V. Hoppe, 1993, FEBS letters.

High Percentage of False-Positive Results of Cytokeratin 19 RT-PCR in Blood: A Model for the Analysis of Illegitimate Gene Expression

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 2000, Oncology.

Low density lipoprotein enhances the thrombin-induced growth of vascular smooth muscle cells.

G. Nickenig, H. Vetter, A. Sachinidis, 1997, Cardiovascular research.

CV-11974, the active metabolite of TCV-116 (Candesarten), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells.

H. Vetter, A. Sachinidis, R. Düsing, 1996, Biochemical pharmacology.

Differential gene expression in synovium of rheumatoid arthritis and osteoarthritis.

K. Schulze-Osthoff, H. Vetter, A. Sachinidis, 2000, Molecular cell biology research communications : MCBRC.

The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar—Kyoto rats

H. Vetter, A. Sachinidis, R. Düsing, 1992, Journal of hypertension.

Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.

T. Brüning, V. Harth, H. Bolt, 2001, Cancer research.

Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat.

W. Vetter, H. Vetter, A. Sachinidis, 1993, Biochemical and biophysical research communications.

Cytokine-inducible growth factor gene expression in human umbilical endothelial cells.

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 1999, Molecular and cellular probes.

Oxymetazoline enhances epidermal- and platelet-derived growth factor-induced DNA synthesis.

G. Nickenig, H. Vetter, A. Sachinidis, 1994, Atherosclerosis.

Short guidelines for real time PCR (genotyping: CYP1A1 IVA, CYP1A1 Msp I, CYP2E1 Rsa I, GSTM1 and GSTT1,GSTP1) [Biomonitoring Methods, 2004]

T. Brüning, Y. Ko, 2012 .

Kurzvorschriften Realtime‐PCR (Genotypisierungen: CYP1A1IVA;CYP1A1 MspI, CYP2E1 RsaI;GSTM1 und GSTT1;GSTP1) [Biomonitoring Methods in German language, 2004]

T. Brüning, Y. Ko, 2012 .

Real-time genotyping of cytochrome P4501A1 A4889G and T6235C polymorphisms.

T. Brüning, V. Harth, H. Bolt, 2001, Molecular and cellular probes.

Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism

T. Brüning, V. Harth, H. Bolt, 1999, Archives of Toxicology.

p53 Downregulation in myelodysplastic syndrome – a quantitative analysis by competitive RT-PCR

K. Schulze-Osthoff, H. Vetter, G. Totzke, 2001, Leukemia.

Kinetics of Na+/H+ exchange in vascular smooth muscle cells from WKY and SHR: effects of phorbol ester.

D. Rosskopf, W. Siffert, H. Vetter, 1995, The American journal of physiology.

Insulin enhances angiotensin II induced DNA synthesis in vascular smooth muscle cells of the rat

H. Vetter, A. Sachinidis, R. Düsing, 1993, The clinical investigator.

Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction.

H. Vetter, A. Sachinidis, H. Zeitler, 1997, European journal of medical research.

Challenges to environmental toxicology and epidemiology: where do we stand and which way do we go?

U Ranft, R Thier, H M Bolt, 2004, Toxicology letters.

Genetic susceptibility to environmental toxicants: the interface between human and experimental studies in the development of new toxicological concepts.

T. Brüning, K. Golka, H. Bolt, 2002, Toxicology letters.

The FASEB Journal express article 10.1096/fj.03-0007fje. Published online November 20, 2003. Mechanisms

K. Schrör, H. Ahn, J. Hescheler, 2022 .

Tumour necrosis factor-α gene expression and production in human umbilical arterial endothelial cells

H. Vetter, A. Sachinidis, T. Neuhaus, 2000 .

Action of dihydropyridine calcium antagonists on early growth response gene expression and cell growth in vascular smooth muscle cells

H. Vetter, A. Sachinidis, R. Düsing, 1993, Journal of hypertension.

Action of metoprolol, enalapril, diltiazem, verapamil, and nifedipine on cell growth of vascular smooth muscle cells.

H. Vetter, A. Sachinidis, Y. Ko, 1992, Journal of cardiovascular pharmacology.

Evaluation of susceptibility parameters in occupational and environmental medicine [Biomonitoring Methods, 2004]

V. Harth, H. Bolt, G. Leng, 2012 .

Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.

T. Brüning, K. Golka, H. Bolt, 2003, International journal of hygiene and environmental health.

A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction.

T. Brüning, S. Stier, H. Vetter, 2002, Molecular and cellular probes.

Inhibition of glycosphingolipid synthesis by threo‐1‐phenyl‐2‐decanoylamino‐3‐morpholino‐1‐propanol (PDMP) and the modulation of IL‐1β‐stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells

A. Sachinidis, A. Weber, Y. Ko, 1998, British journal of pharmacology.

Regulation of Gadd45a mRNA expression in vascular smooth muscle under growth and stress conditions.

A. Sachinidis, R. Kettenhofen, J. Hoppe, 2001, Cellular signalling.

Green tea compounds inhibit tyrosine phosphorylation of PDGF β‐receptor and transformation of A172 human glioblastoma

H. Ahn, A. Sachinidis, Y. Ko, 2000, FEBS letters.

Gangliosides GM1 and GM2 Induce Vascular Smooth Muscle Cell Proliferation via Extracellular Signal-Regulated Kinase 1/2 Pathway

J. Hescheler, A. Sachinidis, I. Gouni-Berthold, 2001, Hypertension.

NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer

T. Brüning, V. Harth, J. Abel, 2000, Archives of Toxicology.

Identification of a phosphodiesterase I/nucleotide pyrophosphatase-related gene mRNA in rat vascular smooth muscle cells by the differential display approach.

H. Vetter, A. Sachinidis, R. Kettenhofen, 1998, Journal of molecular biology.

Cholera toxin treatment of vascular smooth muscle cells decreases smooth muscle α‐actin content and abolishes the platelet‐derived growth factor‐BB‐stimulated DNA synthesis

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 2000, British journal of pharmacology.

Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood.

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Iron-deficiency anemia as the sole manifestation of celiac disease

H. Vetter, R. Düsing, Y. Ko, 1994, The clinical investigator.

Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck.

T. Brüning, V. Harth, H. Bolt, 2001, Carcinogenesis.

Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells.

H. Vetter, A. Sachinidis, R. Düsing, 1997, Atherosclerosis.

Gangliosides GM1 and GM2 Stimulate Vascular Smooth Muscle Cell Growth and the Mitogen-Activated Protein Kinase Signaling Transduction Pathway

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 2000, Hypertension.

Inhibition of the platelet‐derived growth factor β‐receptor tyrosine‐phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins

H. Ahn, J. Hescheler, A. Sachinidis, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Human endothelial cells selectively express large amounts of pancreatic‐type ribonuclease (RNase 1)

J. Olivot, P. Friedl, P. Hewett, 2002, Journal of cellular biochemistry.

Effect of vitamin E and vitamin C on the DNA synthesis of human umbilical arterial endothelial cells

H. Vetter, A. Sachinidis, C. Metzner, 2001, European journal of nutrition.

Identification of syntenin and other TNF‐inducible genes in human umbilical arterial endothelial cells by suppression subtractive hybridization

K. Schulze-Osthoff, S. Stier, A. Sachinidis, 2000, FEBS letters.

Reverse transcriptase-polymerase chain reaction (RT-PCR): a sensitive method to examine basic fibroblast growth factor-induced expression of the early growth response gene-1 (egr-1) in human umbilical arterial endothelial cells.

H. Vetter, A. Sachinidis, U. Schmitz, 1995, Molecular and cellular probes.

High-density lipoprotein reduces epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells.

H. Vetter, A. Sachinidis, Y. Ko, 1993, Atherosclerosis.

[Swelling of the ears, chest pain, cough].

H. Vetter, Y. Ko, G. Nickenig, 1996, Praxis.

Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.

H. Vetter, A. Sachinidis, J. Hoppe, 1996, European journal of cell biology.

Evidence that lipoproteins are carriers of bioactive factors.

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 1999, Arteriosclerosis, Thrombosis and Vascular Biology.

The growth-promoting effect of low-density lipoprotein may Be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway.

H. Vetter, A. Sachinidis, Y. Ko, 1997, Molecular pharmacology.

Lysophosphatidic acid stimulates protein kinase C isoforms α, β, ε, and ζ in a pertussis toxin sensitive pathway in vascular smooth muscle cells

H. Vetter, A. Sachinidis, Y. Ko, 1999 .

Inhibition of angiotensin II and platelet-derived growth factor-induced vascular smooth muscle cell proliferation by calcium entry blockers

H. Vetter, A. Sachinidis, R. Düsing, 1992, The clinical investigator.

Competitive reverse transcription/polymerase chain reaction for the quantification of p53 and mdm2 mRNA expression.

H. Vetter, A. Sachinidis, G. Totzke, 1996, Molecular and cellular probes.

Synergistic action of angiotensin II, insulin-like growth factor-I, and transforming growth factor-beta on platelet-derived growth factor-BB, basic fibroblastic growth factor, and epidermal growth factor-induced DNA synthesis in vascular smooth muscle cells.

H. Vetter, A. Sachinidis, Y. Ko, 1993, American journal of hypertension.

Effects of authentic and VLDL hydrolysis‐derived fatty acids on vascular smooth muscle cell growth

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 2001, British journal of pharmacology.

Oligodeoxynucleotides directed to early growth response gene-1 mRNA inhibit DNA synthesis in the smooth muscle cell.

H. Vetter, A. Sachinidis, R. Düsing, 1996, European journal of pharmacology.

Early intracellular signalling pathway of ethanol in vascular smooth muscle cells

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 1999, British journal of pharmacology.

Lipid‐induced changes in vascular smooth muscle cell membrane fluidity are associated with DNA synthesis

Z. Darżynkiewicz, C. Potten, K. Sasaki, 1999, Cell proliferation.

original article & The American Society of Gene Therapy Identification of Differentially Expressed Genes Involved in the Formation of Multicellular Tumor

J. Hescheler, A. Sachinidis, C. Voolstra, 2006 .

Regulation of angiotensin AT1 receptor gene expression during cell growth of vascular smooth muscle cells.

G. Nickenig, H. Vetter, A. Sachinidis, 1996, European journal of pharmacology.

Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway

H. Vetter, A. Sachinidis, I. Gouni-Berthold, 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

Cell-cycle arrest in G0/G1 phase of growth factor-induced endothelial cell proliferation by various calcium channel blockers.

H. Vetter, A. Sachinidis, H. Zeitler, 1997, Cancer Detection and Prevention.

Angiotensin type-1 (AT1) receptor gene expression in primarily cultured human arterial umbilical endothelial cells.

S. Stier, H. Vetter, A. Sachinidis, 1997, Biochemical pharmacology.

Detection of cytochrome P450 1B1 Bfr I polymorphism: genotype distribution in healthy German individuals and in patients with colorectal carcinoma.

T. Brüning, H. Bolt, J. Abel, 1999, Pharmacogenetics.

Losartan inhibits the angiotensin II-induced stimulation of the phosphoinositide signalling system in vascular smooth muscle cells.

A. Görg, H. Vetter, A. Sachinidis, 1992, European journal of pharmacology.

Native low-density lipoprotein (LDL) induces the expression of the early growth response gene-1 in human umbilical arterial endothelial cells.

H. Vetter, A. Sachinidis, G. Totzke, 1995, European journal of cell biology.

Rapid analysis of GSTM1, GSTT1 and GSTP1 polymorphisms using real-time polymerase chain reaction.

T. Brüning, V. Harth, H. Bolt, 2000, Pharmacogenetics.

Role of mitogen-activated protein kinase in the angiotensin II-induced DNA synthesis in vascular smooth muscle cells.

Y. Ko, H. Vetter, A. Sachinidis, 1998, Hypertension.

The role of platelet‐derived growth factor‐BB‐induced increase in cytosolic free Ca2+ in activation of mitogen‐ activated protein kinase and DNA synthesis in vascular smooth muscle cells

A. Sachinidis, R. Kettenhofen, Y. Ko, 1997, Journal of hypertension.

EXP3174, a metabolite of losartan (MK954, DuP753) is more potent than losartan in blocking the angiotensin ll-induced responses in vascular smooth muscle cells

H. Vetter, A. Sachinidis, R. Düsing, 1993, Journal of hypertension.